Guardant Health, Inc. (GH) financial statements (2021 and earlier)

Company profile

Business Address 505 PENOBSCOT DR.
REDWOOD CITY, CA 94063
State of Incorp. DE
Fiscal Year End December 31
SIC 8071 - Medical Laboratories (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,795523419
Cash and cash equivalents833143141
Short-term investments962380278
Receivables534836
Inventory, net of allowances, customer advances and progress billings23159
Inventory23159
Other undisclosed current assets17115
Total current assets:1,888597469
Noncurrent Assets
Operating lease, right-of-use asset37 
Property, plant and equipment634431
Long-term investments and receivables24726978
Long-term investments24726978
Intangible assets, net (including goodwill)1912 
Goodwill33 
Intangible assets, net (excluding goodwill)169 
Other noncurrent assets1752
Other undisclosed noncurrent assets0368
Total noncurrent assets:383365118
TOTAL ASSETS:2,272963587
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities304218
Accounts payable71611
Accrued liabilities23267
Deferred revenue9 
Debt  0
Deferred compensation liability281913
Other undisclosed current liabilities 1216
Total current liabilities:677347
Noncurrent Liabilities
Long-term debt and lease obligation848 0
Long-term debt, excluding current maturities806  
Capital lease obligations0
Operating lease, liability42 
Liabilities, other than long-term debt228
Deferred compensation liability, classified 0 
Deferred rent credit  8
Other liabilities220
Other undisclosed noncurrent liabilities 407
Total noncurrent liabilities:8494216
Total liabilities:91611562
Temporary equity, carrying amount575042
Stockholders' equity
Stockholders' equity attributable to parent, including:1,298798483
Additional paid in capital1,9021,150764
Accumulated other comprehensive income (loss)31(0)
Accumulated deficit(607)(353)(281)
Other undisclosed stockholders' equity attributable to parent000
Total stockholders' equity:1,298798483
TOTAL LIABILITIES AND EQUITY:2,272963587

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
Revenues28721491
Cost of revenue(90)(66)(42)
Gross profit:19714849
Operating expenses(452)(230)(142)
Operating loss:(255)(82)(93)
Nonoperating income141410
Investment income, nonoperating10145
Other nonoperating income405
Interest and debt expense(5)(1)(1)
Loss from continuing operations before income taxes:(246)(70)(84)
Income tax expense (benefit)(0)2(0)
Net loss:(246)(68)(84)
Net loss attributable to noncontrolling interest(8)(8)(1)
Net loss attributable to parent:(254)(76)(85)
Preferred stock dividends and other adjustments (1)(1)
Other undisclosed net income available to common stockholders, basic 11
Net loss available to common stockholders, diluted:(254)(76)(85)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
Net loss:(246)(68)(84)
Other comprehensive income210
Comprehensive loss:(245)(67)(84)
Comprehensive loss, net of tax, attributable to noncontrolling interest(8)(8)(1)
Comprehensive loss, net of tax, attributable to parent:(252)(74)(85)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: